Chang HR - Search Results

1

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.

Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D. Ping Z, et al. Among authors: chang hr. Oncotarget. 2016 Dec 6;7(49):80655-80663. doi: 10.18632/oncotarget.13019. Oncotarget. 2016. PMID: 27811364 Free PMC article.

2

Induction of MUC1-specific cellular immunity by a recombinant BCG expressing human MUC1 and secreting IL2.

He J, Shen D, O'Donnell MA, Chang HR. He J, et al. Among authors: chang hr. Int J Oncol. 2002 Jun;20(6):1305-11. Int J Oncol. 2002. PMID: 12012014

3

Surgical treatment of breast cancer in previously augmented patients.

Karanas YL, Leong DS, Da Lio A, Waldron K, Watson JP, Chang H, Shaw WW. Karanas YL, et al. Plast Reconstr Surg. 2003 Mar;111(3):1078-83; discussion 1084-6. doi: 10.1097/01.PRS.0000046667.56931.E1. Plast Reconstr Surg. 2003. PMID: 12621177

4

Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses.

Shen D, Chang HR, Chen Z, He J, Lonsberry V, Elshimali Y, Chia D, Seligson D, Goodglick L, Nelson SF, Gornbein JA. Shen D, et al. Among authors: chang hr. Biochem Biophys Res Commun. 2005 Jan 7;326(1):218-27. doi: 10.1016/j.bbrc.2004.10.214. Biochem Biophys Res Commun. 2005. PMID: 15567174 Clinical Trial.

5

In silico identification of breast cancer genes by combined multiple high throughput analyses.

Shen D, He J, Chang HR. Shen D, et al. Among authors: chang hr. Int J Mol Med. 2005 Feb;15(2):205-12. Int J Mol Med. 2005. PMID: 15647832

6

Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.

Prati R, Apple SK, He J, Gornbein JA, Chang HR. Prati R, et al. Among authors: chang hr. Breast J. 2005 Nov-Dec;11(6):433-9. doi: 10.1111/j.1075-122X.2005.00125.x. Breast J. 2005. PMID: 16297088

7

Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.

Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L. Shen D, et al. Among authors: chang hr. Hum Pathol. 2006 Dec;37(12):1583-91. doi: 10.1016/j.humpath.2006.06.001. Epub 2006 Aug 10. Hum Pathol. 2006. PMID: 16949910

8

Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry.

He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR. He J, et al. Among authors: chang hr. Int J Oncol. 2007 Jan;30(1):145-54. Int J Oncol. 2007. PMID: 17143523

9

Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR. Whelan SA, et al. Among authors: chang hr. J Proteome Res. 2009 Aug;8(8):4151-60. doi: 10.1021/pr900322g. J Proteome Res. 2009. PMID: 19522481 Free PMC article.

10

Proteomics and mass spectrometry for cancer biomarker discovery.

Lu M, Faull KF, Whitelegge JP, He J, Shen D, Saxton RE, Chang HR. Lu M, et al. Among authors: chang hr. Biomark Insights. 2007 Oct 3;2:347-60. Biomark Insights. 2007. PMID: 19662217 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters